• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺移植活检中排斥和损伤的分子评估。

Molecular assessment of rejection and injury in lung transplant biopsies.

机构信息

Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.

Alberta Transplant Applied Genomics Center, Edmonton, Alberta, Canada.

出版信息

J Heart Lung Transplant. 2019 May;38(5):504-513. doi: 10.1016/j.healun.2019.01.1317. Epub 2019 Feb 6.

DOI:10.1016/j.healun.2019.01.1317
PMID:30773443
Abstract

BACKGROUND

Improved understanding of lung transplant disease states is essential because failure rates are high, often due to chronic lung allograft dysfunction. However, histologic assessment of lung transplant transbronchial biopsies (TBBs) is difficult and often uninterpretable even with 10 pieces.

METHODS

We prospectively studied whether microarray assessment of single TBB pieces could identify disease states and reduce the amount of tissue required for diagnosis. By following strategies successful for heart transplants, we used expression of rejection-associated transcripts (annotated in kidney transplant biopsies) in unsupervised machine learning to identify disease states.

RESULTS

All 242 single-piece TBBs produced reliable transcript measurements. Paired TBB pieces available from 12 patients showed significant similarity but also showed some sampling variance. Alveolar content, as estimated by surfactant transcript expression, was a source of sampling variance. To offset sampling variation, for analysis, we selected 152 single-piece TBBs with high surfactant transcripts. Unsupervised archetypal analysis identified 4 idealized phenotypes (archetypes) and scored biopsies for their similarity to each: normal; T-cell‒mediated rejection (TCMR; T-cell transcripts); antibody-mediated rejection (ABMR)-like (endothelial transcripts); and injury (macrophage transcripts). Molecular TCMR correlated with histologic TCMR. The relationship of molecular scores to histologic ABMR could not be assessed because of the paucity of ABMR in this population.

CONCLUSIONS

Molecular assessment of single-piece TBBs can be used to classify lung transplant biopsies and correlated with rejection histology. Two or 3 pieces for each TBB will probably be needed to offset sampling variance.

摘要

背景

提高对肺移植疾病状态的认识至关重要,因为失败率很高,通常是由于慢性肺移植物功能障碍。然而,即使进行了 10 次活检,对肺移植经支气管活检(TBB)的组织学评估也很困难,而且往往无法解释。

方法

我们前瞻性地研究了单个 TBB 能否通过微阵列评估来识别疾病状态并减少诊断所需的组织量。通过采用心脏移植成功的策略,我们使用排斥相关转录物(在肾移植活检中注释)的无监督机器学习表达来识别疾病状态。

结果

所有 242 个单块 TBB 均产生可靠的转录测量值。12 名患者的配对 TBB 块显示出显著的相似性,但也显示出一些采样差异。肺泡内容物,如表面活性剂转录物的表达,是采样差异的来源。为了抵消采样变化,在分析中,我们选择了 152 个具有高表面活性剂转录物的单个 TBB 进行分析。无监督原型分析确定了 4 种理想化的表型(原型),并对每个表型的相似性进行了评分:正常;T 细胞介导的排斥(TCMR;T 细胞转录物);抗体介导的排斥(ABMR 样;内皮转录物);和损伤(巨噬细胞转录物)。分子 TCMR 与组织学 TCMR 相关。由于该人群中 ABMR 较少,因此无法评估分子评分与组织学 ABMR 的关系。

结论

单个 TBB 的分子评估可用于对肺移植活检进行分类,并与排斥组织学相关。每个 TBB 需要 2 或 3 个切片来抵消采样差异。

相似文献

1
Molecular assessment of rejection and injury in lung transplant biopsies.肺移植活检中排斥和损伤的分子评估。
J Heart Lung Transplant. 2019 May;38(5):504-513. doi: 10.1016/j.healun.2019.01.1317. Epub 2019 Feb 6.
2
Molecular T-cell‒mediated rejection in transbronchial and mucosal lung transplant biopsies is associated with future risk of graft loss.经支气管和黏膜肺移植活检的分子 T 细胞介导的排斥与未来移植物丧失的风险相关。
J Heart Lung Transplant. 2020 Dec;39(12):1327-1337. doi: 10.1016/j.healun.2020.08.013. Epub 2020 Aug 26.
3
Defining a natural killer cell-enriched molecular rejection-like state in lung transplant transbronchial biopsies.在肺移植经支气管活检中定义富含自然杀伤细胞的分子排斥样状态。
Am J Transplant. 2023 Dec;23(12):1922-1938. doi: 10.1016/j.ajt.2023.06.003. Epub 2023 Jun 7.
4
Building a tissue-based molecular diagnostic system in heart transplant rejection: The heart Molecular Microscope Diagnostic (MMDx) System.构建心脏移植排斥反应的基于组织的分子诊断系统:心脏分子显微镜诊断(MMDx)系统。
J Heart Lung Transplant. 2017 Nov;36(11):1192-1200. doi: 10.1016/j.healun.2017.05.029. Epub 2017 May 29.
5
The molecular diagnosis of rejection in liver transplant biopsies: First results of the INTERLIVER study.肝移植活检中排斥反应的分子诊断:INTERLIVER 研究的初步结果。
Am J Transplant. 2020 Aug;20(8):2156-2172. doi: 10.1111/ajt.15828. Epub 2020 Apr 9.
6
Comprehensive Analysis of Transcript Changes Associated With Allograft Rejection: Combining Universal and Selective Features.全面分析与同种异体移植排斥反应相关的转录变化:结合通用和选择性特征。
Am J Transplant. 2017 Jul;17(7):1754-1769. doi: 10.1111/ajt.14200. Epub 2017 Feb 25.
7
Subthreshold rejection activity in many kidney transplants currently classified as having no rejection.许多目前被归类为无排斥反应的肾移植中存在亚阈值排斥活动。
Am J Transplant. 2025 Jan;25(1):72-87. doi: 10.1016/j.ajt.2024.07.034. Epub 2024 Aug 6.
8
Molecular phenotyping of rejection-related changes in mucosal biopsies from lung transplants.肺移植黏膜活检中排斥反应相关变化的分子表型分析。
Am J Transplant. 2020 Apr;20(4):954-966. doi: 10.1111/ajt.15685. Epub 2019 Dec 1.
9
Assessing rejection-related disease in kidney transplant biopsies based on archetypal analysis of molecular phenotypes.基于分子表型的原型分析评估肾移植活检中与排斥相关的疾病。
JCI Insight. 2017 Jun 15;2(12). doi: 10.1172/jci.insight.94197.
10
Many heart transplant biopsies currently diagnosed as no rejection have mild molecular antibody-mediated rejection-related changes.许多目前诊断为无排斥反应的心脏移植活检存在轻度分子抗体介导的排斥反应相关变化。
J Heart Lung Transplant. 2022 Mar;41(3):334-344. doi: 10.1016/j.healun.2021.08.004. Epub 2021 Aug 26.

引用本文的文献

1
Nanotechnology-driven advancements in organ transplantation: Multifaceted strategies for organ preservation, ischemia reperfusion injury, immunomodulation and post-transplant monitoring.纳米技术推动的器官移植进展:器官保存、缺血再灌注损伤、免疫调节及移植后监测的多方面策略
Mater Today Bio. 2025 Aug 25;34:102245. doi: 10.1016/j.mtbio.2025.102245. eCollection 2025 Oct.
2
Application of artificial intelligence and machine learning in lung transplantation: a comprehensive review.人工智能和机器学习在肺移植中的应用:综述
Front Digit Health. 2025 May 1;7:1583490. doi: 10.3389/fdgth.2025.1583490. eCollection 2025.
3
Treatment Responses in Histologic Versus Molecular Diagnoses of Lung Rejection.
组织学与分子诊断肺排斥反应的治疗反应。
Transpl Int. 2024 Jul 26;37:12847. doi: 10.3389/ti.2024.12847. eCollection 2024.
4
Precision diagnostics in transplanted organs using microarray-assessed gene expression: concepts and technical methods of the Molecular Microscope® Diagnostic System (MMDx).利用微阵列评估基因表达进行移植器官的精准诊断:Molecular Microscope® Diagnostic System(MMDx)的概念和技术方法。
Clin Sci (Lond). 2024 Jun 5;138(11):663-685. doi: 10.1042/CS20220530.
5
Application possibilities of artificial intelligence in facial vascularized composite allotransplantation-a narrative review.人工智能在面部血管化复合组织移植中的应用可能性——一篇叙述性综述
Front Surg. 2023 Oct 30;10:1266399. doi: 10.3389/fsurg.2023.1266399. eCollection 2023.
6
Molecular monitoring of lung allograft health: is it ready for routine clinical use?肺移植后健康的分子监测:是否已准备好常规临床应用?
Eur Respir Rev. 2023 Nov 22;32(170). doi: 10.1183/16000617.0125-2023. Print 2023 Dec 31.
7
Theseus and the search for an antibody-mediated rejection molecular state in lung transplant biopsies.忒修斯与肺移植活检中抗体介导排斥反应分子状态的探寻。
Am J Transplant. 2023 Dec;23(12):1826-1827. doi: 10.1016/j.ajt.2023.08.003. Epub 2023 Aug 9.
8
A survey of the currently known mast cell mediators with potential relevance for therapy of mast cell-induced symptoms.目前已知的肥大细胞介质的调查,这些介质可能与肥大细胞引起的症状的治疗有关。
Naunyn Schmiedebergs Arch Pharmacol. 2023 Nov;396(11):2881-2891. doi: 10.1007/s00210-023-02545-y. Epub 2023 May 27.
9
Molecular Profiling of Tissue Samples with Chronic Rejection from Patients with Chronic Lung Allograft Dysfunction: A Pilot Study in Cystic Fibrosis Patients.慢性肺移植物功能障碍患者慢性排斥反应组织样本的分子谱分析:囊性纤维化患者的初步研究。
Biomolecules. 2023 Jan 3;13(1):97. doi: 10.3390/biom13010097.
10
Revisiting transplant immunology through the lens of single-cell technologies.通过单细胞技术重新审视移植免疫学。
Semin Immunopathol. 2023 Jan;45(1):91-109. doi: 10.1007/s00281-022-00958-0. Epub 2022 Aug 18.